Repligen | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Agilent USD 6.03B 129M 2025-01
Align Technology USD 3.79B 57.74M 2025-03
Bio Techne USD 2.02B 60.47M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Bruker USD 1.83B 35.8M 2025-03
Charles River Laboratories USD 3.19B 267.17M 2025-03
Danaher USD 50.85B 1.31B 2025-03
Dentsply International USD 2.01B 68M 2025-03
Exact Sciences USD 2.4B 5.34M 2025-03
General Electric USD 19.25B 314M 2025-03
Henry Schein USD 3.31B 83M 2025-03
Illumina USD 2.37B 5M 2025-03
IQVIA Holdings USD 5.98B 90M 2025-03
Mettler Toledo International USD -181982000 55.09M 2025-03
Myriad Genetics USD 704.9M 3.8M 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Repligen USD 1.99B 12.76M 2025-03
Revvity USD 7.64B 29.74M 2025-03
Standard Biotools USD 471.72M 17.61M 2024-12
Thermo Fisher Scientific USD 49.36B 227M 2025-03
Waters USD 1.96B 133.89M 2025-03
West Pharmaceutical Services USD 2.68B 800K 2025-03



Repligen Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.